Previous 10 | Next 10 |
IRVINE, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced positive outcomes of the ful...
Inari Medical ( NASDAQ: NARI ), a health equipment company focused on venous diseases, traded lower in the afternoon hours Tuesday as Truist launched its coverage with a Hold recommendation citing the rivalry in an otherwise attractive market opportunity for venous thromboemboli...
Summary Shares are down 25% year to date. Covid limited Inari's ability to develop the DVT market, so a post-pandemic constructive hospital environment provides them a nice tailwind going forward. Product offerings including ClotTriever are providing superior outcomes for pati...
IRVINE, Calif., Sept. 02, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will host th...
IRVINE, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced three new data sets will be ...
Although shares closed up 5% , Inari Medical ( NASDAQ: NARI ) at one point Wednesday afternoon was up ~14% , its biggest one-day gain since March 2021. The medical device company sells equipment for the interventional treatment of venous diseases. Volume was si...
IRVINE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced planned enrollment of the DEFIANCE trial. ...
Penumbra's operating performance has been up to par lately, including better-than-expected gross margins, but a rerating of growth med-tech has hit the shares harder than most. Management is trying to achieve a delicate balancing act between investing in REAL VR (a high-potential imme...
Inari Medical, Inc. (NARI) Q2 2022 Earnings Conference Call August 03, 2022, 05:00 PM ET Company Participants Caroline Corner - IR Bill Hoffman - President and CEO Mitch Hill - CFO Drew Hykes - COO Tom Tu - CMO Conference Call Participants Cec...
Image source: The Motley Fool. Inari Medical, Inc. (NASDAQ: NARI) Q2 2022 Earnings Call Aug 03, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Inari Medical, Inc. (NARI) Q2 2022 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...
2024-06-01 18:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...